Displaying 1 - 9 of 9
Metabolism, Alcohol & Toxicity
5

Madrigal: Identifying, Managing and Treating Patients with NASH and Significant Fibrosis – Current Practice and Future Perspectives - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Madrigal: Identifying, Managing and Treating Patients with NASH and Significant Fibrosis – Current Practice and Future Perspectives - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Madrigal: Identifying, Managing and Treating Patients with NASH and Significant Fibrosis – Current Practice and Future Perspectives - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Madrigal: Identifying, Managing and Treating Patients with NASH and Significant Fibrosis – Current Practice and Future Perspectives - ILC 2022

View
General Hepatology
4

Mirum: Patient, caregiver, and physician: Understanding perspectives in adult and paediatric cholestasis - ILC 2022

View
General Hepatology
4

Mirum: Patient, caregiver, and physician: Understanding perspectives in adult and paediatric cholestasis - ILC 2022

View
General Hepatology
4

Mirum: Patient, caregiver, and physician: Understanding perspectives in adult and paediatric cholestasis - ILC 2022

View
General Hepatology
4

Mirum: Patient, caregiver, and physician: Understanding perspectives in adult and paediatric cholestasis - ILC 2022

View
Immune-Mediated and Cholestatic Diseases
1

BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists - ILC 2022

View
Displaying 1 - 9 of 9